....
|
|
|
- のぶあき はらしない
- 9 years ago
- Views:
Transcription
1 Vol. 22 No
2 1/2 EE F FAF 60E FIP cx 60 10M5 Vol. 22 No
3 carpal tunnel syndrome entrapment neuropathy cm 4 Vol. 22 No
4 5 Vol. 22 No microglobulin 1/2 1/2 night tingling 1 myxedema 2 3 double lesion neuropathy night tingling
5 de Quervain Tinel Tinel Tinel Phalen perfecttest Tinel90 98 Phalen83 tourniquet test60 21 median nerve compression test Vol. 22 No
6 7 Vol. 22 No X CTMRI cm 4.5msec 3.5msec subclinical double lesion neuropathy X MRI B12 10 perfectotest) O
7 8 Vol. 22 No ml 1290 Camitz Camitz Camitz
8 Entrapment neuropathy. MOOK , , Entrapment neuropathy. pp , pp , , pp , , , , pp , Vol. 22 No
9 R hemodialysis, HD peritoneal dialysis, PD /3 HD 17.7PD PD HDPD 2.0PD /3 PD HD1947 PD QOL PD Vol. 22 No
10 mOsm/kg Na 132 meq/l K 0.0 meq/l Ca 2.5 meq/l or 4.0 meq/l P 0.0 mg/dl BUN 0.0 mg/dl Cr 0.0 mg/dl continuous ambulatory peritoneal dialysis 24 L automated peritoneal dialysis PD cycle CAPD QOL nightly peritoneal dialysis R BaxterPD R Vol. 22 No
11 continuous cyclic peritoneal dialysis NPD NPD NPD NPD CAPD tidal peritoneal dialysis APD 50NPD CAPD CAPD24NPD HD HD PD 200ml 20kg 100ml/ PDPD HD CAPD2L1L Na 137 meq/l m Eq10g APDNaNa Na6090mEq/L Vol. 22 No
12 800 mg PD toxic shock shock PD PD HD PD PD D 75 high turn over bone D g g 1,25 PTHAlp low turn over bone D 14 Vol. 22 No
13 6.0mg/dL 4.0 CaCa4 8.0mg/dL D 8.5mEq/L Dry weight Ca ACE 50100ng/mL HD PD 100/kg Hb 300 /kg ACE IGF-I catch-up Department of Health & Human Services. United States Renal Data System.1999 Annual Data Report. Maryland, US. NIH, , CAPDII.. CAPD1990. Vol. 22 No
14 ddddddddddddddddddddddddddddddddddddddddddddd ddddddddddddddddddddddddddddddddddddddddddddd Vol. 22 No
15 T TT TTT 18 Vol. 22 No
16 T IMHC TTIMHC TIMHC T TTT Vol. 22 No
17 DNA DNA T DNADNA DNA T 20 Vol. 22 No
18 ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 10Vol.20 No.10 Vol.21 No.3 10mg20mg40mg 20mg 20mg10mg 40mg Vol. 22 No
19 24 Vol. 22 No
20 25 Vol. 22 No ?
21 Vol. 22 No
22 DI REPORT 27 Vol. 22 No DI 50 mm P 21G 25 B P G B-D mg/dL mg/dL 1550L g H P 21G S P G B-D mg/dL 50L g H H S mg/dL L g H
23 DI REPORT M B-D 30G B-D 30G G G G DM mg/dL 20600mg/dL 20600mg/dL L L L mm g 60g 45g H H H Vol. 22 No
24 DI REPORT 29 Vol. 22 No mm B-D 30G G G G DM mg/dL L g H S S mg/dL g H N LNH 2.5mL mg/dL L g H
25 DI REPORT Z Inc. Inc Z LNH 3000 CROM mg/dL 500mg/dL 500mg/dL L 10L 10L mm g 102g H9. 6 H H H12. 2 H Vol. 22 No
26 DI REPORT QID G G ml mg/dL 20600mg/dL 20600mg/dL 3.5L L L mm g 18g 60g 95g H H H H H H H11. 2 H12. 1 H9. 6 H9. 2 H9. 2O/T No PRACTICE Vol. 15 No Vol. 22 No
27 4B 12 4B 32 Vol. 22 No
28 NHK 1973 Vol. 22 No
29 N.I.Vavilov 20 F.N.Meyer Augustin Pyrame de Candolle Vol. 22 No
30 to-mo to-mo Prunusplum persica Perusicum mālum Persicum presica pesca peschepeche pêche peche14peach16 Vol. 22 No
31 peach peche PfirsichPfirsichbaum Pesca Prunus persica(l.)batsch (Amygdalus persica L.) m 15cm 1.5cm cm kaempferol cumarin amygdalin24-24-methylencycloartanol 7-7 -avenasterol40 emulsin 1712 g 30g 500g 36 Vol. 22 No
32 1318 Vol. 22 No
33 Vol. 22 No
34 39 Vol. 22 No
35 TEL Vol. 22 No
36 OK 40OK OK OKOK OK Vol. 22 No
37 42 Vol. 22 No
38 43 Vol. 22 No PR A 12 OTC 10 OTC 3040
39 44 Vol. 22 No DI TDM TDM
40 45 Vol. 22 No TDM 480 1,500 G OTC100 OTC 100
41 46 Vol. 22 No OTC OTC OTC 1020 OTCH2 70 H2 OTC OTC
42 47 Vol. 22 No TDM TDM TDM TDM 10 EBM
43 48 Vol. 22 No OTC 21 10
44 49 Vol. 22 No AB
45 50 Vol. 22 No
46 50 Vol. 22 No
47 QOL CAPD Vol. 22 No
48 53 Vol. 22 No JA 56.4BC
49 54 Vol. 22 No
50 55 Vol. 22 No /4 14
51 Col N. et al : The role of medication noncompliance and adverse drug reaction on hospitalizations of the elderly. Arc Intern Med. 150 : , p. 217 Lamy PP. : Adverse drug effects. Clin Geriatr Med. 6 : , 1990 J Okuno et al. : Compliance and medication knowledge among elderly Japanese home-care recipients. Eur J Clin Pharmcol. 55 : , Vol. 22 No
52 Vol. 22 No
53 58 Vol. 22 No
54 59 Vol. 22 No ;; ;; ;; ;; ;; ;; ;; ;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;; ;;; ;;; ;;; ;;; ;;; ;;; ;;;;; ;;;;; ;;;;; ;;;;; ;;; ;;; ;;; ;;; ;;; ;;; ;;; ;;;;;;; ;;;;;;; ;;;;;;; ;;;;;;;
55 60 Vol. 22 No a b c d 10 QOL
56 61 Vol. 22 No QOL OTC ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;; ;;; ;;; ;;; ;;; ;;; ;;;
57 Vol. 22 No
58 65 Vol. 22 No JR10 1, JR10 3, JR ;; ;; ;; ;; DDDDDD DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD
59 66 Vol. 22 No
60 68 Vol. 22 No PI , YMCA
61 69 Vol. 22 No Na Q&A 2, NKS Tel
62 70 Vol. 22 No , JR10 JR10 JR 21
M1 TSH T 3 T 4 2 T 1 2 Plummer 3 TSH TSH K 5 7 TSH TSH Plummer TSH TSH TSH TSH T 4 T 3 TSH T 4 T 3 TSH TSH or Plummer Plummer or a) 1. 2. 3. b) 1. T 4 T 3 2. TSH 0.1 U/ml 3. TSH TRAb TSAb 4. 1) a) 1
DM
( ) FAX DM DM PR 300 - - - - - - - - - - - - - - - - - - 6 3 1 4 3 - - - - PR P173 FAX (2001) (2000) (1999) 1986 http://kimono-yamato.com/04-kiso/qa.html Q&A http://web.sfc.keio.ac.jp/~t00524sh/chousa/rich/kimonobegin.html
07.報文_及川ら-二校目.indd
8 01 01 4 4 1 5 16 18 6 006 H 18 4 011 H 6 4 1 5 1 5 007 H 19 5 009 1 5 006 007 009 011 9 10 4 000 H 1 4 5 004 H 16 4 004 009 H 1 5 4 4 5 1 4 006 011 1 1 4m 5m 10m 007 1 7 009 009 1 5 10 1 000kg 10a 006
紀要No.9_006王_CS.indd
1 2 3 4 5 87 9 2009 1937.1 6 1937.1 2 1937.3 1937.9 73 1941.6 77 1941.10 27 1943.9 1943.10 1944.12 1946.12 1947.1 5 1948.4 L 1949.9 10 1950.10 1953.1 1953.12 1956.5.16 1956.6 1966.9 30 1966.10 1967.4 1967.9
BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI
20 2 2015 1 2 3 85 K CT Abstract A case of renal subcapsular hematoma resulting from trigger point injection under excessive effect of anticoagulant YAMANE Tateki, UMEDA Akira and SHIMAO Hitoshi An 85-year-old
無印良品 2012 自転車 カタログ
26 897895321,000 140cm 76.0cm 16.0kg H LED 3 263 897896025,000 140cm 76.0cm 16.5kg H 3 LED 20 8978984 8978977 19,800 134cm 73.0cm 15.0kg LED 2620 2620 8486656550 5536207483 14512372,100 8279999840 26 77342561,417
125 2 P 1st washout 2 PB P mg/dL nd washout 2 P 5.5mg/dL< mg/dL <2.5mg/dL P P 2 D D 3 Ca 10
. (1) 125 1 125 Renagel PB-94 P intact-pth P 1 b c a b 1 18 2 3 3 3 1 P 4 D 1 5 6 7 2 1HIV 2 3 4 5Hb 8.0g/dL ALT 48IU/L 6 7 PB-94 440mg 403mg 1-196 125 2 P 1st washout 2 PB-94 1 2 4 4 P 2.5 5.5mg/dL 1
取扱説明書 [F-12C]
F-12C 11.7 1 2 3 4 5 6 7 8 9 10 11 12 13 14 a bc b c d d a 15 a b cd e a b c d e 16 17 18 de a b 19 c d 20 a b a b c a d e k l m e b c d f g h i j p q r c d e f g h i j n o s 21 k l m n o p q r s a X
1 2 3 4 1 3 4 2 5 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 21 24 25 26 27 28 29 30 31 32 33 34 9 35 36 14 9 14 15 37 38 39 35 1 519 4 NPO 40 41 9 10 4 (9 Or10 ) PR 3 21 21 42 2 10 43 44 15
臨床神経 indd
164 41 3 CTS CTS Key Words : carpal tunnel syndrome, nerve conduction study, sensory nerve action potential CTS CTS 10 1 2 CTS 1 3 4 CTS 1 Tinel Phalen Tinel CTS 1 Phalen Phalen Phalen Phalen 2 1/3 : 1
2 5 28 4 1 47 2
4 4 5 28 1 2 5 28 4 1 47 2 10 10 22 78 10 28 2 2 10% NHK 30% 32% 3 4 5 1 150 1 5 1 20 2 3 1 2008 2 2 2009 2009 3 3 4 DNA 1 3 2 1 3 3 1 5 3 5 8 18 8 30 5 3 2 60 1 5 2 3 60 2 2 2 60 1 1 5 150 6 3 1 2 150
37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate
37, 9-14, 2017 : 36 2015 8 6 cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin 20 1983 2016 3 CD 7 Clostridium difficile CD CD associated diarrhea : CDAD CD 1,2 PPI 3 1 36 33 2015 8 6 5 5
3675-433897418-1.pdf
A : : : : : : : : : : PR PR NHK 2 PR PR 3 1954 7 4 5 9 12,000 12 100 2 2 11 4 5 6 7 / PR 8 9 10 11 1952 ( ) 2008 2009 2012 NHK km m m 12 m km km kg kg 13 % 14 15 1959 5 20 8 17100kg 400kg How much? 60
1 P2 P P3P4 P5P8 P9P10 P11 P12
1 P2 P14 2 3 4 5 1 P3P4 P5P8 P9P10 P11 P12 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 & 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 1! 3 2 3! 4 4 3 5 6 I 7 8 P7 P7I P5 9 P5! 10 4!! 11 5 03-5220-8520
「若年不安定就労・不安定住居者聞取り調査」報告書
2008 3 2006 2007 3 19 6 7 5,400 2007 4 5 19 94 1 2 2007 5 i 2007 6 12 100 100 1 2 2008 3 ii 1960 1990 iii = 1990 = = iv 5 5 v & = 2 24 = 1990 10 vi vii i iii 1 3 1.1.............................................
1) a) b) CRP c) d) e) a,b b,c c,d d,e a,e b,d 2) CKD a) ACE ARB b) 2mg/dL ACE ARB c) 2mg/dL d) e) ACE ARB a,b b,c c,d d,e a,e b,d 3) a) 130/85mmHg b)
2010.1.13 1) 4) 2 18 1) 1 2 3 4 2) 1 2 85 3 3) 1 metabolizer 2 metabolizer 3 metabolizer 4 metabolizer 4) CYP 1 2 metabolizer 3 metabolizer 4 5 6 4 7 2 5 (PPI) 1 2 PPI 2 3 2 3 3 3 3 PPI 3 1 ph 4 5 1) 5)
Vol.171 2004.9.15 14 100 5 10 15 52 53 55 1 7 55 58 63 3 26 53 3 6 9 2 3 6 9 6 52 53 55 3 9 5 1 7 10 14 4 12 8 11
Vol.170 2004.9.9 9 17 9 17 1000 8 10 9 17 14:00 17:00 30 28 Vol.171 2004.9.15 14 100 5 10 15 52 53 55 1 7 55 58 63 3 26 53 3 6 9 2 3 6 9 6 52 53 55 3 9 5 1 7 10 14 4 12 8 11 9.17 10 15 38 51 53 55 6 2
DocuPrint C5450 ユーザーズガイド
1 2 3 4 5 6 7 8 1 10 1 11 1 12 1 13 1 14 1 15 1 16 17 1 1 18 1 19 1 20 1 21 1 22 1 23 1 24 1 25 1 26 27 1 1 28 1 29 1 30 1 31 1 2 12 13 3 2 10 11 4 9 8 7 6 5 34 24 23 14 15 22 21 20 16 19 18 17 2 35
1 2 3 4 10 5 30 87 50 20 3 7 2 2 6 3 70 7 5 10 20 20 30 14 5 1,000 24 112 2 3 1 8 110 9 JR 10 110 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 25 30 31 32 25 A 33 B C D E F G PR PR or 34 35
2005 6 7 15 2006 3 shokuiku shokuiku 2
2005 6 7 15 2006 3 shokuiku shokuiku 2 shokuiku 3 (shokuiku) (shokuiku) (shokuiku) (shokuiku) 4 ( ) 2005 7 15 2006 4 5 shokuiku shokuiku 1 2 3 shokuiku shokuiku shokuiku 6 1 ( ) 15~64 1992 65 2050 40%
140 120 100 80 60 40 20 0 115 107 102 99 95 97 95 97 98 100 64 72 37 60 50 53 50 36 32 18 H18 H19 H20 H21 H22 H23 H24 H25 H26 H27 1 100 () 80 60 40 20 0 1 19 16 10 11 6 8 9 5 10 35 76 83 73 68 46 44 H11
福岡大学人文論叢47-3
679 pp. 1 680 2 681 pp. 3 682 4 683 5 684 pp. 6 685 7 686 8 687 9 688 pp. b 10 689 11 690 12 691 13 692 pp. 14 693 15 694 a b 16 695 a b 17 696 a 18 697 B 19 698 A B B B A B B A A 20 699 pp. 21 700 pp.
労働法総論講義(2・完)
173 174 175 176 .... 177 ............ NHK NHK.. NHK.................. 178 ........ 179 180 181 182 183 .. 184 185 186 187 .............. 188 .. 189 .. 190 .. 191 192 193 .. 194 195 196 .............. 197
() 2
1 () 2 2 4 3 6,500 4 5 2 6 A B A B A B A B - A B 7 8 A B A B A B 9 JR JR 10 11 6 5 12 17 6 13 14 B A A B A B A B 2 1 8 15 8 16 17 9 18 3 4 5 mm mm 19 2 20 3 6 7 11 12 13 14 18 4 3 2 1 21 3 12 13 14 16
<82D282A982C1746F95F18D908F57967B95B E696E6464>
1 2 (90cm 70cm 2015) 3 (68cm 28cm 30cm 12kg 2015) (77.5 109.5cm 2015) 4 (22cm 50cm 50cm 4.6kg 2015) (45cm 62.5cm 2015) (47.4cm 62.5cm 2014) 5 (28.5cm 23.5cm) (45cm 62cm 2015) (97cm 107cm 2015) 6 7 8 9
6 12 10661 93100 227213202 222208197 85kg cm 20 64.521 106856142 2 1 4 3 9767 100 35 cm 7747 208198 90kg 23 5828 10661 93100 cm 227213202 10639 61 64.521 85kg 78kg 70kg 61 100 197204.5 cm 15 61
180 140 22
21 180 140 22 23 25 50 1 3 350 140 500cm 600 140 24 25 26 27 28 29 30 31 1/12 8.3 1/15 6.7 10 1/8 12.5 1/20 140 90 75 150 60 150 10 30 15 35 2,000 30 32 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9 % 100 50 33.3
合併後の交付税について
(1) (2) 1 0.9 0.7 0.5 0.3 0.1 2 3 (1) (a), 4 (b) (a), (c) (a) 0.9 0.7 0.5 0.3 0.1 (b) (d),(e) (f) (g) (h) (a) (i) (g) (h) (j) (i) 5 (2) 6 (3) (A) (B) (A)+(B) n 1,000 1,000 2,000 n+1 970 970 1,940 3.0%
国試過去問集.PDF
I 89 16 3 130 ab c AMPcAMP a 1 --- b c --- 2 --- --- 3 --- --- 4 --- --- 5 --- --- camp camp Ca 2+ β1 camp A camp camp A β1 p.156 β p.146 b. p.157 p135 (ANP) p157 c PDE-III p.157 p.157, 183 PDE C Ca PDE-III
0.45m1.00m 1.00m 1.00m 0.33m 0.33m 0.33m 0.45m 1.00m 2
24 11 10 24 12 10 30 1 0.45m1.00m 1.00m 1.00m 0.33m 0.33m 0.33m 0.45m 1.00m 2 23% 29% 71% 67% 6% 4% n=1525 n=1137 6% +6% -4% -2% 21% 30% 5% 35% 6% 6% 11% 40% 37% 36 172 166 371 213 226 177 54 382 704 216
10 117 5 1 121841 4 15 12 7 27 12 6 31856 8 21 1983-2 - 321899 12 21656 2 45 9 2 131816 4 91812 11 20 1887 461971 11 3 2 161703 11 13 98 3 16201700-3 - 2 35 6 7 8 9 12 13 12 481973 12 2 571982 161703 11
21 3 1 1 1 2 3 3 3 4 10 14 17 18 20 21 35 41 47 48 48 49 49 54 59 59 63 67 72 86 86 87 88 88 88 89 90 94 115 8 20 6 1 2 266.5km 2 227.5km 2 85% 39.1km 2 15% 3 17,281 34.6% 4 5 6 14 20 %
10
2005 APR no.76 P P P P11P22 P2 P29 P30 P32 / / 787-8501 -10 TEL3-1111 FAX0120-59787 http//www.city.nakamura.kochi.jp/ http://www.city.nakamura.kochi.jp/i/ [email protected] 10 10 10 29
新入_本文.smd
52 28 220 28 4 1 017-777-1511 2 2 8 2 9 8 9 47.2% 12.8% 11.5% 6.0% 4 2 (49.6%)(13.0%) (14.7%) (7.4%)(8.4%) (52.3%)(9.1%) (11.4%) (10.0%) 33.0% 23.4% 15.6% 9.6% (26.0%) (18.3%) (46.5%) (30.0%) (20.0%) 2
緑化計画作成の手引き 26年4月版
http://www.city.shibuya.tokyo.jp/env/en_eventact/midori_ryokka.html 10 11 12 13 14 15 16 17 18 19 P10 P10 1 P12 2635 Fax (1) 47 03-5388-3554 http://www2.kankyo.metro.tokyo.jp/sizen/sinseisyo/e2/tebiki.htm
近畿中国四国農業研究センター研究報告 第7号
230 C B A D E 50m 558 0 1km (mg L 1 ) T N NO 2 3 N NH 4 N 2.0 0 (a) 2001 1.5 6 20 21 5 1.0 0.5 0.0 2.0 1.5 1.0 0.5 0.0 14:00 17:00 (b) 2001 7 3 4 20:00 23:00 2:00 (h) 5:00 8:00 11:00 10 0 5 10 15
取扱説明書 [F-02F]
F-02F 4. 2 3 4 5 6 7 8 9 0 2 3 4 5 6 7 8 a b c d a b c d a b cd 9 e a b c d e 20 2 22 ab a b 23 a b 24 c d e 25 26 o a b c p q r s t u v w d h i j k l e f g d m n a b c d e f g h i j k l m n x 27 o
QOL 02 QOL QOL UI AI EAThoracotomy TTThoracoscopy TS QOL EA type-c y score UI 3 AI 8 School score QOL score 12
54 1 2018 2 4-1 OK-432 1 15 14 15 US CT MRI 17 cm 0.16 g/kg/day OK-432 3 1 ke 2 2 ke 3 1 1,150 ml 13 US OK-432 4-2 TJ-28 TJ-28 2003 3 2017 6 250 TJ-28 44 16 28 TJ-28 7 2 46 8.5 2 2 9 34 79.1 10 23.3 34
(事務局)
10. JR JR JR OK - 1 - JR.5 JR JR JR JR JR - 2 - NO1 IT 1.5 F PR - 3 - PR - 4 - JR - 5 - - 6 - - 7 - 8 45 JR 11-8 - 5 120 2 40 14 28 20 28 14 20-9 - 45 JR - 10 - JR JR JR JR JR JR JR JR JR JR JR JR JR JR
thermometer AnnuAl RepoRt 2011 Terumo CorporaTion
2011 2011 3 1921 10 thermometer 1921 1853 1931 AnnuAl RepoRt 2011 Terumo CorporaTion 2011 5 01 Introduction MRS. GIeSeKe 1994 DuraHeart DuraHeartDuraHeart 5 DuraHeart DuraHeart DuraHeart duraheart 2007
Taro10-名張1審無罪判決.PDF
-------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -1- 39 12 23 36 4 11 36 47 15 5 13 14318-2-
ml DNA DNA
ml DNA DNA ml PH HO DNADNA DNA LED LED CD CD ch 概 概 mll IC LED OK CD CDDVD CD LED LED LED The LED PVA Part LED LED PPT V LED AI LED V AlCu Fe Al Al PVA ml 概 概 CD CD OHP etc cm PET cm PET cm PET LED LED
(1.2) T D = 0 T = D = 30 kn 1.2 (1.4) 2F W = 0 F = W/2 = 300 kn/2 = 150 kn 1.3 (1.9) R = W 1 + W 2 = = 1100 N. (1.9) W 2 b W 1 a = 0
1 1 1.1 1.) T D = T = D = kn 1. 1.4) F W = F = W/ = kn/ = 15 kn 1. 1.9) R = W 1 + W = 6 + 5 = 11 N. 1.9) W b W 1 a = a = W /W 1 )b = 5/6) = 5 cm 1.4 AB AC P 1, P x, y x, y y x 1.4.) P sin 6 + P 1 sin 45
Contents 4 06 IP2 41 Thermo Scientific Nalgene Nalgene
Nalgene & Packaging plastic Bottles & Vials Contents 4 06 IP2 41 Thermo Scientific Nalgene 5 07 42 8 08 43 9 09 45 11 10 46 Nalgene 12 11 50 13 12 53 01 20 13 61 02 28 14 64 03 33 15 66 04 37 16 / 67 05
1 2 2 ANCA pouci immune IgG C3 ANCA 68 '01 '02 7 UN 14mg/dl, Cr 0.7 mg/dl, -, - ' UN 45mg/dl, Cr 2.4 mg/dl, Ht 29.5%, 4+, cm 61
1 2 2 ANCApouci immune IgG C3 ANCA 68 '01 '02 7 UN 14mg/dl, Cr 0.7 mg/dl, -, - '03 2 3 31 UN 45mg/dl, Cr 2.4 mg/dl, Ht 29.5%, 4+, 3+ 4 14 156.0 cm 61.5 kg 36.9 158/92 mmhg 90 1. ANCA 2. 3. IgG4 deposit
3 9 3 100 2 10 30 12 1 1 2 2 4 3 9 1 250-1- 3 12 2 2 4 2 16 2-2- -3-8 2 6 10 30 11 30 11 2,500 9 2 2 10-4- 2005 2005 5 50-5- 3 30 FM 43 18 23 730 1700 17 11 3 FM 2 1800 30 3 400 1 1 28 3 4 18.1.28-6- 1
Understanding Stem Cell Transplant 2007
Understanding Stem Cell Transplant IMF International Myeloma Foundation 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607 USA Telephone: 800-452-CURE (2873) (USA & Canada) 818-487-7455 Fax: 818-487-7454
21 5 I C T J-Doit High risk Risk 20 7 21 34,324 30,858 38,735 26,800 27,490 20,472 18,533 20,096 14,913 14,931 488 470 491 435 446 10 t-pa intervention t-pa interventionclipping simulator subspecialty
中高生を中心とした子供の生活習慣づくりに関する検討委員会 第3回 配付資料その3
( 2 1) 1)-1: 1025 20081367775 800mg 800mg800mg800mg 800mg800mg [Osami Akimitsu, Kai Wada, TerukiNoji, NozomiTaniwaki, MiladaKrejci, Miyo Nakade, Hitomi Takeuchiand Tetsuo Harada (2013) The relationship
北アルプス_燕岳~穂高_-2.doc
1 ( )22 2001 2226 30 1300m 27kg 2 JR 1000 22 10 3 500-400 au 300 N 2763m 4 N N 10 N 500m PM9:00 5 ( 2 ) 7 23 2001 2226 10 N N 40 10 30 6 5m N N N 12 3 49 30 20 2922m 7 K ( ) U S N ( ) 50 15 N 35 (2758m)
